PDCD1 and neoplasm: Analysis of AMG 510 in mouse models with KRASG12C-injected tumors resulted in tumor regression, and combining this molecule with chemotherapy (carboplatin) or ICI (anti-PD-1) resulted in a further increase in tumor regression [130].